Indian’s ban on imports of refurbished medical devices is disrupting the supply of affordable diagnostic and treatment equipment, but local medtech startups hold significant potential to address the gaps in product availability.
Indian Startups Look To Fill The Void Left By The Refurbished Medical Device Ban
The burgeoning medtech startup ecosystem in India has shown promise in innovation – can it step up?
Indian startups hold significant potential to address the gap created by the ban on import of refurbished medical products, but they face challenges on several fronts and call for more government support.
More from Startups & SMEs
More from Geography
• By
Medtech has not yet been spared from the Trump administration’s trade tariffs, which, for UK exporters will be 10% – half the rate applied to EU27 exporters.
• By
Medical devices, diagnostics, and equipment face tariffs announced by President Donald Trump, despite industry pleas for exemption. The tariffs, ranging from 10%-49%, impact most countries trading with the US, potentially hindering innovation and increasing costs in the medtech sector.
• By
The US FDA has published its final document to guide sponsors on using sex-specific data in designing clinical trials of medical devices. However, the guidance removes all references to gender that appeared in January’s draft guidance, released before the Trump administration took office.